Idorsia Ltd (SWX:IDIA)

Switzerland · Delayed Price · Currency is CHF

3.535

-0.355 (-9.13%)

At close: Mar 12, 2026

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Discovering, Developing and Commercializing Drugs			152.39M	97.10M	35.35M	71.76M	23.82M
Discovering, Developing and Commercializing Drugs Growth			56.93%	174.70%	-50.74%	201.26%	-60.71%
Total			152.39M	97.10M	35.35M	71.76M	23.82M
Total Growth			56.93%	174.70%	-50.74%	201.26%	-60.71%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States			24.41M	5.54M	-	-	-
United States Growth			340.36%	-	-	-	-
Switzerland			88.03M	46.58M	35.35M	71.76M	23.82M
Switzerland Growth			88.99%	31.77%	-50.74%	201.26%	-60.71%
EUCAN			6.28M	1.00M	-	-	-
EUCAN Growth			525.90%	-	-	-	-
Japan			33.66M	43.98M	-	-	-
Japan Growth			-23.45%	-	-	-	-
Total			152.39M	97.10M	35.35M	71.76M	23.82M
Total Growth			56.93%	174.70%	-50.74%	201.26%	-60.71%

Source: S&P Global Market Intelligence.